MyMD Pharmaceuticals Inc (MYMD): What's with the nearly 6 million sha...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	682
Boards Moderated	0
Alias Born	06/26/2013

knuts4oe

Re: None

Tuesday, 08/31/2021 11:21:10 AM

Tuesday, August 31, 2021 11:21:10 AM

What's with the nearly 6 million share BID at .0009 !!!!!

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent MYMD News

Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 01:04:23 PM
MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer • Business Wire • 06/17/2024 01:00:00 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 05/31/2024 12:00:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 01:10:03 PM
MyMD Pharmaceuticals Secures Strategic Investments • Business Wire • 05/21/2024 01:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:01:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 04:00:19 PM
MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing • Business Wire • 03/05/2024 02:15:00 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:13:35 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:27:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:57:03 PM
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing • Business Wire • 02/13/2024 04:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 02:15:12 PM
MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis • Business Wire • 12/06/2023 02:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 01:00:10 PM
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain • Business Wire • 10/19/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 09:00:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:30:23 PM
MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023 • Business Wire • 10/04/2023 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:24:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 09:58:33 PM

More MYMD News

InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover